Market Tracker

04/25 4:04am ET

PDL BioPharma Inc (NASDAQ:PDLI)

8.42
Data as of Apr 24
 -0.06 / -0.71%
Today’s Change
7.38
Today|||52-Week Range
10.21
-0.24%
Year-to-Date

Today’s Trading

Previous close8.48
Today’s open8.50
Day’s range8.40 - 8.55
Volume2,448,258
Average volume (3 months)3,403,694
Market cap$1.3B
Dividend yield7.13%
Data as of 3:59pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+17.00%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio4.9
Price/Sales2.66
Price/Book10.14

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-0.46-0.66%
AUXLAuxilium Pharmaceuti...+0.22+0.80%
ARNAArena Pharmaceutical...+0.01+0.16%
INSYInsys Therapeutics I...+0.20+0.47%
Data as of 04/24/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)$0.47
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts